Cargando…
Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases—Retrospective Analysis of 219 Patients
SIMPLE SUMMARY: Appropriate therapies for brain metastases are still lacking and need further research, especially in terms of recurrent brain metastases. This is why we decided to highlight the importance of complete cytoreduction by addressing the impact of postoperative tumor burden as displayed...
Autores principales: | Lin, Jonas, Kaiser, Yannik, Wiestler, Benedikt, Bernhardt, Denise, Combs, Stephanie E., Delbridge, Claire, Meyer, Bernhard, Gempt, Jens, Aftahy, Amir Kaywan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605169/ https://www.ncbi.nlm.nih.gov/pubmed/37894435 http://dx.doi.org/10.3390/cancers15205067 |
Ejemplares similares
-
Brain metastases in the elderly – Impact of residual tumor volume on overall survival
por: Baumgart, Lea, et al.
Publicado: (2023) -
The Impact of Postoperative Tumor Burden on Patients With Brain Metastases
por: Aftahy, Amir Kaywan, et al.
Publicado: (2022) -
The Bigger the Better? Analysis of Surgical Complications and Outcome of the Retrosigmoid Approach in 449 Oncological Cases
por: Aftahy, Amir Kaywan, et al.
Publicado: (2022) -
A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis
por: Aftahy, A. Kaywan, et al.
Publicado: (2023) -
Metabolic Parameters Influence Brain Infarction and Outcome after Resection of Brain Metastases
por: Lange, Nicole, et al.
Publicado: (2020)